The prostate cancer therapeutics market is expected to grow from US$ 14,767.73 million in 2022 to US$ 28,425.27 million by 2030; it is anticipated to record a CAGR of 8.5% from 2022 to 2030. Prostate cancer is one of the most common health problems in men, especially in older men (aged above 50 years. Prostate […]
